A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The primary purpose of the study is to investigate the plasma pharmacokinetics and bioavailability (BA) of a single dose of a solid dose formulation with 2 different strengths of JNJ-54175446 (50 milligram \[mg\] and 100 mg capsules) relative to the suspension of JNJ-54175446 under fasting conditions.
Epistemonikos ID: a20177f115c0edf6162b9b36628eaa0546a493d7
First added on: May 17, 2024